Another CD44 variant, CD44v3, binds to several heparan sulfate-binding growth factors such as fibroblast growth factors (FGFs) and heparin-binding epidermal growth factor (HB-EGF), and induces tumor progression (17,18). This evidence concerns the gene CD44 and neoplasm.